drugset / Trial / NCT04716751
Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open, II phase study to evaluate the safety and efficacy of Toripalimab + carboplatin + paclitaxel in 15 newly diagnosed patients with tracheal malignant tumors.
Timeline
- Start
- 2021-02-01
- Primary completion
- 2022-01-31
- Completion
- 2025-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toripalimab | Monoclonal antibody | 240 mg | Intravenous |
| Background | Carboplatin | Small molecule | 5 unknown | Intravenous |
| Background | Paclitaxel | Small molecule | 200 mg/m2 | Intravenous |